Impact of bioregulation therapy on the course of retinitis pigmentosa in older people

DOI: https://doi.org/10.29296/25877305-2020-06-14
Download full text PDF
Issue: 
6
Year: 
2020

Professor S. Trofimova(1), MD; Professor Y. Datseris(2), MD; A. Trofimov(3), MD; R. Diamanti(2) (1)Saint Petersburg Institute of Bioregulation and Gerontology (2)OMMA Ophthalmology Hospital, Athens, Greece (3)OOO «Tree of Life. Clinic», Saint Petersburg

The paper presents the results of 30-year clinical use of peptide retinoprotectors in the treatment of degenerative retinal diseases, retinitis pigmentosa in particular. The findings suggest that peptide retinoprotectors have a high clinical effect and that these peptide drugs are promising for use in older people.
Keywords: 
ophthalmology
peptide retinoprotectors
peptide bioregulators
retinitis pigmentosa
retinal dystrophy

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. DOI: 10.1006/exer.2001.1118
  2. Vanyushin B.F., Khavinson V.Kh. Short Biologically Active Peptides as Epigenetic Modulators of Gene Activity. W. Doerfler, P. Böhm (eds.). Epigenetics – A Different Way of Looking at Genetics. Springer International Publishing Switzerland, 2016; p. 69–90.